Rechel B, Ahmedov M, Akkazieva B, Katsaga A, Khodjamurodov G, McKee M. Lessons from two decades of health reform in Central Asia. Health Policy Plan. 2012;27(4):281–7.
Article
CAS
PubMed
Google Scholar
Rechel B, McKee M. Health reform in central and eastern Europe and the former Soviet Union. Lancet. 2009;374(9696):1186–95.
Article
PubMed
Google Scholar
Mathauer I, Theisling M, Mathivet B, Vilcu I. State budget transfers to health insurance funds: extending universal health coverage in low- and middle-income countries of the WHO European Region. Int J Equity Health. 2016;15(1):57.
Article
PubMed
PubMed Central
Google Scholar
Ibraimova A, Akkazieva B, Ibraimov A, Manzhieva E, Rechel B. Kyrgyzstan: Health system review. 2011.
Kutzin J, Cashin C, Jakab M. Implementing health financing reform. Geneva: World Health Organisation; 2010.
Google Scholar
Falkingham J, Akkazieva B, Baschieri A. Trends in out-of-pocket payments for health care in Kyrgyzstan, 2001–2007. Health Policy Plan. 2010;25(5):427–36.
Article
PubMed
PubMed Central
Google Scholar
Giuffrida A, Jakab M, Dale EM. Toward universal coverage in health: The case of the state guaranteed benefit package of the Kyrgyz Republic. Washington: World Bank; 2013.
Google Scholar
OECD. Social Protection System Review of Kyrgyzstan, OECD Development Pathways. Paris: OECD Publishing; 2018.
Book
Google Scholar
Waning B, Maddix J, Soucy L. Balancing medicine prices and business sustainability: analyses of pharmacy costs, revenues and profit shed light on retail medicine mark-ups in rural Kyrgyzstan. BMC Health Services Res. 2010;10(1):205.
Article
Google Scholar
Waning B, Maddix J, Tripodis Y, Laing R, Leufkens HG, Gokhale M. Towards equitable access to medicines for the rural poor: analyses of insurance claims reveal rural pharmacy initiative triggers price competition in Kyrgyzstan. Int J Equity in Health. 2009;8(1):43.
Article
Google Scholar
Akkazieva B, Jakab M, Temirov A. Long-term trends in the financial burden of health care seeking in Kyrgyzstan, 2000–2014. World Health Organization, WHO Barcelona Office for Health Systems Strengthening: Copenhagen; 2016.
Google Scholar
Jakab M, Akkazieva B, Habicht J. Can people afford to pay for health care? New evidence on financial protection in Kyrgyzstan. WHO Regional Office for Europe, WHO Barcelona Office for Health Systems Strengthening: Copenhagen; 2018.
Google Scholar
Wagner AK, Graves AJ, Reiss SK, LeCates R, Zhang F, Ross-Degnan D. Access to care and medicines, burden of health care expenditures, and risk protection: Results from the World Health Survey. Health Policy. 2011;100(2):151–8.
Article
PubMed
Google Scholar
Damme WV, Leemput LV, Hardeman W, Meessen B. Out-of-pocket health expenditure and debt in poor households: evidence from Cambodia. Tropical Med Int Health. 2004;9(2):273–80.
Article
Google Scholar
Leive A, Xu K. Coping with out-of-pocket health payments: empirical evidence from 15 African countries. Bull World Health Organ. 2008;86(11):849–56C.
Article
PubMed
PubMed Central
Google Scholar
Van Doorslaer E, O'Donnell O, Rannan-Eliya RP, Somanathan A, Adhikari SR, Garg CC, et al. Catastrophic payments for health care in Asia. Health Econ. 2007;16(11):1159–84.
Article
PubMed
Google Scholar
Falkingham J. Poverty, out-of-pocket payments and access to health care: evidence from Tajikistan. Soc Sci Med. 2004;58(2):247–58.
Article
PubMed
Google Scholar
Ensor T. Informal payments for health care in transition economies. Soc Sci Med. 2004;58(2):237–46.
Article
PubMed
Google Scholar
Janevic T, Sarah PW, Leyla I, Elizabeth BH. Individual and community level socioeconomic inequalities in contraceptive use in 10 Newly Independent States: a multilevel cross-sectional analysis. Int J Equity Health. 2012;11(1):69.
Article
PubMed
PubMed Central
Google Scholar
Belli P, Gotsadze G, Shahriari H. Out-of-pocket and informal payments in health sector: evidence from Georgia. Health Policy. 2004;70(1):109–23.
Article
PubMed
Google Scholar
Gotsadze G, Bennett S, Ranson K, Gzirishvili D. Health care-seeking behaviour and out-of-pocket payments in Tbilisi, Georgia. Health Policy Plan. 2005;20(4):232–42.
Article
PubMed
Google Scholar
Xu K, Evans DB, Kawabata K, Zeramdini R, Klavus J, Murray CJ. Household catastrophic health expenditure: a multicountry analysis. Lancet. 2003;362(9378):111–7.
Article
PubMed
Google Scholar
World Health Organization. Designing health financing systems to reduce catastrophic health expenditure. Technical Brief for Policy-Makers. No. 2. Geneva: 2005.
Reddy SR, Ross-Degnan D, Zaslavsky AM, Soumerai SB, Wagner AK. Health care payments in the asia pacific: validation of five survey measures of economic burden. Int J Equity Health. 2013;12(1):49.
Article
PubMed
PubMed Central
Google Scholar
Mchenga M, Chirwa GC, Chiwaula LS. Impoverishing effects of catastrophic health expenditures in Malawi. Int J Equity Health. 2017;16(1):25.
Article
PubMed
PubMed Central
Google Scholar
Qosaj FA, Froeschl G, Berisha M, Bellaqa B, Holle R. Catastrophic expenditures and impoverishment due to out-of-pocket health payments in Kosovo. Cost Eff Resour Alloc. 2018;16(1):26.
Article
Google Scholar
Kruk ME, Goldmann E, Galea S. Borrowing And Selling To Pay For Health Care In Low- And Middle-Income Countries. Health Affairs. 2009;28(4):1056–66.
Article
PubMed
Google Scholar
Dugee O, Sugar B, Dorjsuren B, Mahal A. Economic impacts of chronic conditions in a country with high levels of population health coverage: lessons from Mongolia. Tropical Med Int Health. 2019;24(6):715-26.
Article
Google Scholar
Gaal P, Belli PC, McKee M, Szocska M. Informal payments for health care: definitions, distinctions, and dilemmas. J Health Politics Policy Law. 2006;31(2):251–93.
Article
Google Scholar
Cherecheş RM, Ungureanu MI, Sandu P, Rus IA. Defining informal payments in healthcare: A systematic review. Health Policy. 2013;110(2):105–14.
Article
PubMed
Google Scholar
Jakab M, Kutzin J. Improving financial protection in Kyrgyzstan through reducing informal payments: evidence from 2001–2006. Bishkek: World Health Organization; 2008.
Google Scholar
Jakab M, Akkazieva B, Kutzin J. Can reductions in informal payments be sustained? Evidence from Kyrgyzstan, 2001–2013. Barcelona: World Health Organization, WHO Barcelona Office for Health Systems Strengthening; 2016.
Google Scholar
WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies. Glossary of pharmaceutical terms. Update 2018. Vienna: 2018. Available from: https://ppri.goeg.at/ppri-glossary (Accessed 9 Feb 2019).
Gemmill MC, Thomson S, Mossialos E. What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries. Int J Equity Health. 2008;7:12.
Article
PubMed
PubMed Central
Google Scholar
Swartz K. Cost-sharing: effects on spending and outcomes. The Synthesis project. Research synthesis report No. 20. Princton: Robert Wood Johnson Foundation; 2010.
Google Scholar
Luiza VL, Chaves LA, Silva RM, Emmerick ICM, Chaves GC, de Araújo SCF, et al. Pharmaceutical policies: effects of cap and co-payment on rational use of medicines. Cochrane Database Syst Rev. 2015;5:1-152.
Puig-Junoy J, Rodríguez-Feijoó S, Lopez-Valcarcel BG. Paying for Formerly Free Medicines in Spain After 1 Year of Co-Payment: Changes in the Number of Dispensed Prescriptions. Appl Health Econ Health Policy. 2014;12(3):279–87.
Article
PubMed
Google Scholar
Puig-Junoy J, Rodriguez-Feijoo S, Gonzalez Lopez-Valcarcel B, Gomez-Navarro V. Impacto de la reforma del copago farmacéutico sobre la utilizacíon de medicamentos antidiabéticos, antitrombóticos y para la obstrucción crónica del flujo aéreo [Impact of the Pharmaceutical Copayment Reform on the Use of Antidiabetics, Antithrombotics and for Chronic Obstructive Airway Disease Agents]. Rev Esp Salud Publica. 2016;90:e1–e15.
Google Scholar
Fiorio CV, Siciliani L. Co-payments and the demand for pharmaceuticals: evidence from Italy. Econ Model. 2010;27:835–41.
Article
Google Scholar
Austvoll-Dahlgren A, Aaserud M, Vist G, Ramsay C, Oxman AD, Sturm H, et al. Pharmaceutical policies: effects of cap and co-payment on rational drug use. Cochrane Database Syst Rev. 2008;1:CD007017.
Kolasa K, Kowalczyk M. The effects of payments for pharmaceuticals: a systematic literature review. Health Econ Policy Law. 2017;14(3):1–18.
Article
Google Scholar
Mahlich J, Sruamsiri R. Co-insurance and health care utilization in Japanese patients with rheumatoid arthritis: a discontinuity regression approach. Int J Equity Health. 2019;18(1):22.
Article
PubMed
PubMed Central
Google Scholar
Hernández-Izquierdo C, González L-VB, Morris S, Melnychuk M, Abásolo AI. The effect of a change in co-payment on prescription drug demand in a National Health System: The case of 15 drug families by price elasticity of demand. PloS one. 2019;14(3):e0213403.
Article
PubMed
PubMed Central
Google Scholar
Lexchin J, Grootendorst P. Effects of Prescription Drug User Fees on Drug and Health Services Use and on Health Status in Vulnerable Populations: A Systematic Review of the Evidence. Int J Health Serv. 2004;34(1):101–22.
Article
PubMed
Google Scholar
Sinnott SJ, Normand C, Byrne S, Woods N, Whelton H. Copayments for prescription medicines on a public health insurance scheme in Ireland. Pharmacoepidemiol Drug Safety. 2016;25(6):695–704.
Article
Google Scholar
Damiani G, Federico B, Anselmi A, Bianchi CBNA, Silvestrini G, Iodice L, et al. The impact of Regional co-payment and National reimbursement criteria on statins use in Italy: an interrupted time-series analysis. BMC Health Serv Res. 2014;14(1):1–8.
Article
Google Scholar
Maciejewski ML, Farley JF, Parker J, Wansink D. Copayment reductions generate greater medication adherence in targeted patients. Health Affairs. 2010;29(11):2002–8.
Article
PubMed
Google Scholar
Gibson TB, Mark TL, Axelsen K, Baser O, Rublee DA, McGuigan KA. Impact of statin copayments on adherence and medical care utilization and expenditure. Am J Manag Care. 2006;12:11-9.
Gibson TB, Ozminkowski RJ, Goetzel RZ. The effects of prescription drug cost sharing: a review of the evidence. Am J Manag Care. 2005;11(11):730–40.
PubMed
Google Scholar
Eaddy MT, Cook CL, O'Day K, Burch SP, Cantrell CR. How patient cost-sharing trends affect adherence and outcomes: a literature review. Pharm Ther. 2012;37(1):45–55.
Google Scholar
Diao Y, Qian J, Liu Y, Zhou Y, Wang Y, Ma H, et al. Government insurance coverage and use and affordability of expensive targeted anti-cancer medicines in China: an interrupted time-series study. Lancet. 2018;392:S37.
Article
Google Scholar
Seetasith A, Wong W, Tse J, Burudpakdee C. The impact of copay assistance on patient out-of-pocket costs and treatment rates with ALK inhibitors. J Med Econ Online First. 2019;22(5):414–20.
Article
PubMed
Google Scholar
Sensharma A, Yabroff KR. Do interventions that address patient cost-sharing improve adherence to prescription drugs? A systematic review of recently published studies. Expert Review Pharmacoecon Outcomes Res Online First. 2019:1–15.
Schneider P, Vogler S. Pharmaceutical pricing and reimbursement reform in Kyrgyzstan. Copenhagen: WHO Regional Office for Europe, 2016.
Ministry of Health of the Kyrgyz Republic. Kyrgyz Republic National Health Care Reform Program «Manas Taalimi» for 2006–2010. Approved by the Decree of the Government of the Kyrgyz Republic No. 100 as of February 16, 2006. Bischkek: 2006.
WHO Regional Office for Europe. Review of Den Sooluk health sector reform notes improved health outcomes and coordination in Kyrgyzstan. Copenhagen: 9 May 2017. http://www.euro.who.int/en/health-topics/Health-systems/pages/news/news/2017/05/review-of-den-sooluk-health-sector-reform-notes-improved-health-outcomes-and-coordination-in-kyrgyzstan. Accessed 1 July 2018.
MeTA. Medicine Prices, Availability, Affordability in Kyrgyz Republic. Report of a survey conducted September to October 2015. Bishek, 23 November 2015: Medicines Transparency Alliance. MeTA Project in Kyrgyzstan, 2015.
MeTA Secretariat. Kyrgyzstan Pharmaceutical Country Profile. Bishkek, in collaboration with the World Heallth Organization: 2012.
Sarievich C. Development of the pharmaceutical market in Kyrgystan through 2020: market challenges in the Eurasian Economic Union. Presentation at the Pharmaceutical Forum of Commonwealth of Independent States. Moscow: 2016.
Vogler S, Haasis MA, Dedet G, Lam J, Bak PH. Medicines reimbursement policiies in Europe. Copenhagen: World Health Organization; 2018.
Google Scholar
WHO Regional Office for Europe. Robust regulatory framework in Kyrgyzstan will improve financial access to medicines. Copenhagen: 4 July 2018. http://www.euro.who.int/en/countries/kyrgyzstan/news/news/2018/7/robust-regulatory-framework-in-kyrgyzstan-will-improve-financial-access-to-medicines. Accessed 21 July 2018.
National Bank of the Kyrgyz Republic. Official exchange rates. Bishkek: 2017. http://www.nbkr.kg/index1.jsp?item=1562&lang=ENG. Accessed 23 Sept 2017.
Datta BK, Husain MJ, Asma S. Assessing the relationship between out-of-pocket spending on blood pressure and diabetes medication and household catastrophic health expenditure: evidence from Pakistan. Int J Equity Health. 2019;18(1):9.
Article
PubMed
PubMed Central
Google Scholar
Łuczak J, García-Gómez P. Financial burden of drug expenditures in Poland. Health Policy. 2012;105(2):256–64.
Article
PubMed
Google Scholar
Krůtilová V, Yaya S. Unexpected impact of changes in out-of-pocket payments for health care on Czech household budgets. Health Policy. 2012;107(2):276–88.
Article
PubMed
Google Scholar
Baji P, Pavlova M, Gulácsi L, Groot W. Changes in equity in out-of-pocket payments during the period of health care reforms: evidence from Hungary. Int J Equity Health. 2012;11(1):36.
Article
PubMed
PubMed Central
Google Scholar
Sanwald A, Theurl E. Out-of-pocket payments in the Austrian healthcare system–a distributional analysis. Int J Equity Health. 2015;14(1):94.
Article
PubMed
PubMed Central
Google Scholar
Thomson S, Evetovits T, Cylus J. Financial protection in high-income countries. A comparison of the Czech Republic, Estonia and Latvia. Copenhagen: WHO Regional Office for Europe; 2018.
Google Scholar
Thomson S, Murauskienė L. Can people afford to pay for health care? New evidence on financial protection in Lithuania. Copenhagen: WHO Regional Office for Europe, WHO Barcelona Office for Health Systems Strengthening; 2018.
Google Scholar
Acosta A, Ciapponi A, Aaserud M, Vietto V, Austvoll-Dahlgren A, Kösters JP, et al. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies. Cochrane Database Syst Rev. 2014;10(10):1-118.
Vogler S, Österle A, Mayer S. Inequalities in medicine use in Central Eastern Europe: an empirical investigation of socioeconomic determinants in eight countries. Int J Equity Health. 2015;14(1):124.
Article
PubMed
PubMed Central
Google Scholar
Thomson S, Cylus J, Evetovits T. Can people afford to pay for health care? New evidence on financial protection in Europe. Copenhagen: WHO Regional Office for Europe; 2019.
Google Scholar
Callander E, Bates N, Lindsay D, Larkins S, Topp SM, Cunningham J, et al. Long-term out of pocket expenditure of people with cancer: comparing health service cost and use for indigenous and non-indigenous people with cancer in Australia. Int J Equity Health. 2019;18(1):32.
Article
PubMed
PubMed Central
Google Scholar
Lewin S, Glenton C. Are we entering a new era for qualitative research? Using qualitative evidence to support guidance and guideline development by the World Health Organization. Int J Equity Health. 2018;17(1):126.
Article
PubMed
PubMed Central
Google Scholar
WHO HAI. Measuring medicine prices, availability, affordability and price components. 2nd ed. Geneva: World Health Organization, Health Action International; 2008.
Google Scholar
Cameron A, Ewen M, Auton M, Abegunde D. The world medicines situation 2011. Medicines prices, availability and affordability. Geneva: World Health Organization; 2011.
Google Scholar
Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373(9659):240–9.
Article
CAS
PubMed
Google Scholar
Ewen M, Zweekhorst M, Regeer B, Laing R. Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases. PLOS ONE. 2017;12(2):e0171284.
Article
PubMed
PubMed Central
Google Scholar
Niëns LM, Cameron A, Van de Poel E, Ewen M, Brouwer WB, Laing R. Quantifying the impoverishing effects of purchasing medicines: a cross-country comparison of the affordability of medicines in the developing world. PLoS Med. 2010;7(8):1056.
Article
Google Scholar
Zaprutko T, Kopciuch D, Kus K, Merks P, Nowicka M, Augustyniak I, et al. Affordability of medicines in the European Union. Plos one. 2017;12(2):e0172753.
Article
PubMed
PubMed Central
Google Scholar
Lee KS, Shahidullah A, Zaidi ST, Patel RP, Ming LC, Tariq MH, et al. The Crux of the Medicine Prices' Controversy in Pakistan. Front Pharmacol. 2017;8:504.
Article
PubMed
PubMed Central
Google Scholar
Guadamuz GA. The drugs don’t work: access to medicines in the developing world. Alfa Redi: Revista de Derecho Informático. 2005;88:1-30.
World Health Organization. WHO Guideline on Country Pharmaceutical Pricing Policies. Geneva: WHO; 2013.
United Nations Secretary General's High-Level Panel on Access to Medicines. Report of the United Nations Secretary General's High-Level Panel on Access to Medicines. Promoting innovation and access to health technologies. 2016.
Google Scholar
WHO. Fair Pricing Forum. 2017 Meeting Report. Genev: World Health Organization, 2017. Available from: http://www.who.int/medicines/access/fair_pricing/FairPricingForum2017MeetingReport.pdf?ua=1 (Accessed 1 Mar 2019).
Suh G-H. High medicine prices and poor affordability. Curr Opin Psychiatry. 2011;24(4):341–5. https://doi.org/10.1097/YCO.0b013e3283477b68.
Article
PubMed
Google Scholar
Iyengar S, Tay-Teo K, Vogler S, Beyer P, Wiktor S, de Joncheere K, et al. Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis. PLoS Med. 2016;13(5):e1002032.
Article
PubMed
PubMed Central
Google Scholar
Vogler S. Medicine Price Surveys, Analyses and Comparisons. Evidence, Methodology and Guidance. London: Elsevier; 2019.
Google Scholar
Verulava T, Jorbenadze R, Dangadze B, Eliava E. Access to Ambulatory Medicines for the Elderly in Georgia. Home Health Care Manag Pract. 2019;31(2):107–12.
Article
Google Scholar
OECD. Pharmaceutical Pricing Policies in a Global Market. Paris: OECD; 2008.
Book
Google Scholar
Nguyen TA, Knight R, Roughead EE, Brooks G, Mant A. Policy options for pharmaceutical pricing and purchasing: issues for low-and middle-income countries. Health Policy Plan. 2014;30:267-80. czt105.
Article
PubMed
Google Scholar
Hasan SS, Kow CS, Dawoud D, Mohamed O, Baines D, Babar Z-U-D. Pharmaceutical Policy Reforms to Regulate Drug Prices in Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea. Value Health Regional Issues. 2019;18:18–23.
Article
Google Scholar
Ball D. The Regulation of Mark-ups in the Pharmaceutical Supply Chain. Working paper 3, WHO/HAI Project on Medicine Prices and Availability. Geneva: World Health Organization and Health Action International, 2011.
Ministry of Health. eHealth in the Kyrgyz Republic. Strategy and Action Plan 2015–2020. Adopted by Decree No.496 of the Ministry of Health of the Kyrgyz Republic, 24 August 2015, 2015.
Google Scholar
Bigdeli M, Jacobs B, Tomson G, Laing R, Ghaffar A, Dujardin B, et al. Access to medicines from a health system perspective. Health Policy Plan. 2012;7:692–704.
Article
PubMed
PubMed Central
Google Scholar
Dukes MNG, Haaijer-Ruskamp FM, de Joncheere K, Rietveld AH. Drugs and Money. Prices, affordability and cost containment. Amsterdam: World Health Organization; 2003.
Google Scholar
Seiter A. A practical approach to pharmaceutical policy. Washington DC: World Bank Publications; 2010.
Book
Google Scholar
Wagner AK, Quick JD, Ross-Degnan D. Quality use of medicines within universal health coverage: challenges and opportunities. BMC Health Serv Res. 2014;14:357.
Article
PubMed
PubMed Central
Google Scholar
Wirtz VJ, Hogerzeil HV, Gray AL, Bigdeli M, de Joncheere CP, Ewen MA, et al. Essential medicines for universal health coverage. Lancet. 2017;389(10067):403–76.
Article
PubMed
Google Scholar